CHI (Commission for Health Improvement) bows out with report on three years of NHS failings
This article was originally published in Clinica
Severe and sustained staffing shortages and inadequate risk and clinical effectiveness arrangements were among the causes of "serious system failings" in the NHS in England and Wales at operational or clinical speciality level during 2000-03. So says the Commission for Health Improvement (CHI) in a report summarising the findings, implications and impact of its 11 investigations during that period.
You may also be interested in...
Health ministers have called for more action on access to medicines, including a new EU work agenda, rebuilding Europe’s manufacturing capabilities, further action on pricing, and greater leeway for member states to mitigate drug shortages by restricting parallel exports.
China’s Bio-Thera Solutions has received approval from the country’s NMPA to launch a Phase I clinical study comparing the pharmacokinetics and safety of its proposed ustekinumab biosimilar to Johnson & Johnson’s blockbuster psoriasis drug Stelara, the latest in a string of the biotech company’s products to advance into clinical development.